Yanez Michelle — SEC Form 4 filings

SEC reporting owner CIK 1958023. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-03-27 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Inhibitor Therapeutics, Inc. (INTI)Director33
MIRA PHARMACEUTICALS, INC. (MIRA)Chief Financial Officer22
Telomir Pharmaceuticals, Inc. (TELO)Chief Financial Officer11

Form 4 filings — Yanez Michelle

FiledFormIssuerReported transactionsSource
2026-08-044Inhibitor Therapeutics, Inc. (INTI)Grant/award (A): 50,000 @ $0EDGAR
2025-04-074Inhibitor Therapeutics, Inc. (INTI)Grant/award (A): 50,000 @ $0EDGAR
2024-12-104MIRA PHARMACEUTICALS, INC. (MIRA)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2024-09-044Telomir Pharmaceuticals, Inc. (TELO)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2024-05-164Inhibitor Therapeutics, Inc. (INTI)Grant/award (A): 50,000 @ $0EDGAR
2024-03-274MIRA PHARMACEUTICALS, INC. (MIRA)Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1958023 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →